- Ashwin bags six wickets as India hammer Bangladesh in first Test
- Nascent French government under pressure on multiple fronts
- Angry French cognac makers see red over Chinese tariffs threat
- Protect the prosciutto: Italy battles swine fever
- UN holds 'Summit of the Future' to tackle global crises
- Marxist leader set to become Sri Lanka's next president
- From blades to pull-up bars: UK charity tackles knife crime
- Swiss vote on pensions and environment protections
- No pain, no gain: Chinese pro wrestlers fight for recognition
- UAE leader seeks to deepen 'strategic' ties in US visit during Mideast crisis
- Hezbollah takes heavy hits but still fighting Israel
- Floods, landslides hit central Japan months after major quake
- All Blacks coach Robertson demands better finishing
- Argentina edge South Africa to keep title hopes alive
- Biden says China 'testing us,' in hot mic remarks to Quad allies
- Dubois destroys Joshua to retain IBF world heavyweight crown
- Guardiola says critics want Man City wiped 'from face of the Earth'
- Biden says 'Quad' is 'here to stay' despite challenges
- Dubois knocks out Joshua to retain IBF world heavyweight crown
- Vinicius helps 'faster' Madrid overturn stubborn Espanyol
- Zelensky to press US on long-range missile strikes inside Russia
- PSG drop first points in draw at Reims
- Vinicius, Mbappe on target as Madrid crush plucky Espanyol
- Jeeno leads Ko by two at LPGA Queen City Championship
- Bottega Veneta goes for 'E.T.' chic as Madonna pops into D&G
- Messi, Miami frustrated by New York late leveler
- Musk's X platform takes first step toward lifting Brazil ban
- 'Business as usual' for Australia match-winner Carey amid boos
- Israeli jets pound Lebanon after deadly Beirut strike
- Ten Hag bemoans Man Utd's lack of killer instinct in Palace stalemate
- France's Macron appoints new government in shift to right
- Cheika proud of Leicester grit after winning start as boss
- Profligate Man Utd pay price in 0-0 draw at Palace
- Kane, Olise run riot as Bayern thump Bremen
- Diaz fires Liverpool top of Premier League, Man Utd held at Palace
- LIV champion Rahm out of LIV Team semis with severe flu
- Slot surprised by tearful Nunez's moment of magic
- Title rivals Norris, Verstappen on 'cool' front row for Singapore GP
- Biden talks China with 'Quad' leaders in hometown summit
- Juve and Napoli play out goalless draw in early Serie A title tussle
- Alcaraz fears tennis tour grind will 'kill us'
- Carey sparks recovery as Australia thrash England in 2nd ODI
- Leclerc, Sainz lament 'disappointing' Saturday in Singapore
- Bottega Veneta holds investors' aces as Madonna pops into D&G
- Beirut digs for victims at building flattened in Israeli strike
- Verstappen stages protest over 'ridiculous' swearing punishment
- Bayern boss Kompany lauds 'special talent' Olise
- Diaz fires Liverpool top of Premier League, Spurs bounce back
- Heavy fire over Israel-Lebanon border after deadly Beirut strike
- Ramos guides unbeaten Toulouse to Montpellier win despite Hogg scuffle
France to 're-shore' production of 50 key medicines: Macron
France will bring home production of around 50 crucial medications for which it currently depends on imports, President Emmanuel Macron said Tuesday, hoping to battle shortages of items like antibiotics and paracetamol.
Of the initial slate of drugs with a "clear dependence on imports from outside the EU", 25 "will have their production re-shored or significantly increased... in the coming weeks," Macron said during a visit to a pharmaceuticals factory in southern France.
The announcement comes after a March survey by pollsters BVA found 37 percent of people had already run into shortages at the pharmacy.
Up to 80 percent of familiar medications like antibiotics and painkillers used in France are produced abroad, especially in China.
Some of the drugs are still made in France, but at volumes that fail to match demand.
Over the winter, Europe faced shortages of key antibiotic amoxicillin and other medications as surging illnesses particularly among children have increased demand for the drugs.
Under Macron's plan, public money to the tune of 160 million euros ($173 million) will go to support eight of the new projects, including for amoxycillin -- produced by British pharma giant GSK in northwestern France -- as well as anaesthetics, painkillers and cancer drugs.
Companies would be able to apply for a share of a further 50 million euros in funding, Macron said.
The 50 drugs flagged by Macron are among a list of 450 drawn up by the health ministry for which "we must absolutely secure our supply chains, either by completely re-shoring or diversifying (supply) and continuing to innovate," the president said.
Tuesday's pharma announcements mark the first step in a week dedicated to industrial projects, which Macron hopes will move public attention on from the battles over his widely-disliked pension reform.
B.Finley--AMWN